Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

CF gene therapy product enters phase II

Feb. 5, 1997

PDE IV/TNF production inhibitors claimed by Pfizer

Feb. 5, 1997

Positive results reported from TOBI pivotal trials

Feb. 4, 1997

Marnac licenses broad-spectrum antifibrotic drug

Feb. 4, 1997

Piperidine derivatives reported by Schering-Plough

Feb. 4, 1997

Sepracor granted U.S. patent for Claritin metabolite

Jan. 31, 1997

Zyflo now available in U.S.

Jan. 30, 1997

New use claimed for maprotiline

Jan. 29, 1997

Positive results reported for Allervax Ragweed seasonal trial

Jan. 29, 1997

Banyu prepares selective muscarinic antagonists with reduced side effects

Jan. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...